Wednesday, September 11, 2024

CES Therapy (Cranial Electrotherapy Stimulation) for Anxiety and Insomni...


This device can help with insomnia. I use it often and I fall asleep within 15 minutes. I have been using it about 6 years as of this date.

Wednesday, June 26, 2024

Tuesday, March 26, 2024

Chronic Pain? Consider Flossing Treatment of Fascae (Fascia)

Fascia: Cause of Chronic Pain

Medical Frontiers

Fascia is a membrane-like tissue beneath the skin enveloping internal organs. We introduce the latest treatment for shoulder stiffness and lower-back pain utilizing the characteristics of fascia.


Watch here

 https://www3.nhk.or.jp/nhkworld/en/shows/2050156/




Saturday, February 4, 2023

Behind The Bottle | Cardamom


Cardamom Oil  Elettaria cardamomum
Through a collaborative sourcing initiative in Guatemala, doTERRA retrieves high quality Cardamom seeds which are distilled into Cardamom essential oil that can assist with gastrointestinal and respiratory health when ingested.*

Description
A close relative to Ginger, Cardamom is known as an expensive cooking spice and for being beneficial to the digestive system in a variety of ways when ingested.* Cardamom is commonly used internally to help soothe occasional stomach discomfort.* Its distinct scent can promote a positive atmosphere. Ingested Cardamom also has profound effects on the respiratory system due to its high 1,8-cineole content, which promotes clear breathing and respiratory health.* 

Native to Southeast Asia, Cardamom is added to traditional Indian sweets and teas for its cool, minty aroma and flavor. doTERRA Cardamom essential oil is extracted from Cardamom seeds grown in Guatemala, using our strict CPTG® testing standards. Through a collaborative and responsible sourcing arrangement, we are able to have a significant impact on the lives of local partners, ensuring that these farming communities enjoy improved livelihoods.

Uses
Use internally as part of a daily health regimen to support healthy gastrointestinal function.*
Add to bread, smoothies, meats, and salads to enhance food flavor.
Diffuse or inhale for a sense of openness.

Directions For Use
Aromatic use: Use three to four drops in the diffuser of choice.
Internal use: Dilute one drop in 4 fl. oz. of liquid.
Topical use: Apply one to two drops to desired area. Dilute with a carrier oil to minimize any skin sensitivity. See additional precautions below.

Cautions
Possible skin sensitivity. Keep out of reach of children. If you are pregnant, nursing, or under a doctor’s care, consult your physician. Avoid contact with eyes, inner ears, and sensitive areas.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Breathin' Easy with doTERRA TriEase Softgels- A Seasonal Blend

Monday, November 14, 2022

doTERRA BOGO November 2022

 





Order Here/Learn More Here



That’s the power of Lemon! 🍋



Lemon is a good alternative for toxic cleaning products in you home. Clean your counters, clean your windows. It is a well rounded product.



One drop of lemon oil is like putting 28 lemons in a cup of tea.




Cleans kidneys and liver. It is a natural detox.




It is a healthy furniture polish.



Use it in baking (lemon squares). Remember less is more!

Diffuse it to clean the air in your house.


Get doTERRA here and learn more!


Wednesday, November 17, 2021

Heavy Metals in Spices: BEWARE

Saturday, March 27, 2021

The Future of Medicine - Photodynamic Therapy and Nano-medicine - Radio Show

The Future of Medicine - Photodynamic Therapy and Nano-medicine

https://www.blogtalkradio.com/progressintheworld/2021/03/28/the-future-of-medicine--photodynamic-therapy-and-nano-medicine




Join us for this online radio broadcast (Podcast) With Dr. Michael Karlfeldt as we discuss The Future of Medicine – Photodynamic Therapy and Nano-medicine. 12 PM – 2 PM Pacific Call in number 310-861-2349

Ask Dr. Karlfeldt questions live. Please call in and share this broadcast.

Learn About: Chronic disease management (Cancer, chronic infections, autoimmune, neurological) using a targeted nutritional delivery system, laser therapy, repurposed drugs, peptides  and nutraceuticals.

Topics to be discussed:

 

Photodynamic Therapy (PDT) is one of the most interesting and promising approaches for the treatment of various cancers and illnesses. Non-toxic dyes known as photosensitizers are administered systemically, locally or intravenously, and accumulate in the tumor or other lesions. Intravenous and interstitial illumination with visible or infra-red laser light excites the sensitizer, which in the presence of oxygen, produces reactive oxygen species that mediate cytotoxic effects. Undesirable cells such as infectious microbial cells or malignant cancer cells can be selectively killed by this approach.

 

Intravenous PDT brings light directly to the bloodstream through optic fibers inserted through a catheter in a vein. The blood is exposed to different colors, wavelengths, of laser light. This process, called blood irradiation, heightens the body’s immune response to kill infections, circulating tumor cells and tumor stem cells.





Nanomedicine, an offshoot of nanotechnology, refers to highly specific medical intervention at the molecular scale for curing disease. Nanomedicine technology inspired by platelet-derived microparticles (PMPs). These membrane fragments, PMPs, shed from activated platelets. This type of delivery system’s advantages are that there are no detrimental side effects, and the practitioners can use a hyper-targeting system to get the drugs, peptides and nutraceuticals exactly where they are needed.






Practitioners could also utilize this type of technology to accelerate regenerative therapies, such as those for the bone, vascular, heart, cartilage, bladder, and brain tissue that aims to restore, maintain or enhance tissues and hence organ functions.


Contact Dr. Michael Karlfeldt


www.thekarlfeldtcenter.com  


HealthMade Radio www.healthmade.co

 

IntegrativeTrueHealthTVShow  www.truehealthshow.com 


Instagram bio link (canva.com) http://aoscansolex.com/dr-karlfeldt 


Phone 208.338.8902 

Wednesday, July 22, 2020

GPR 55



G protein-coupled receptor 55 also known as GPR55 is a G protein-coupled receptor that in humans is encoded by the GPR55 gene.[5]
GPR55, along with GPR119 and GPR18, have been implicated as novel cannabinoid receptors.[6][7]

History[edit]

GPR55 was identified and cloned for the first time in 1999.[8] Later it was identified by an in silico screen as a putative cannabinoid receptor because of a similar amino acid sequence in the binding region.[9] Research groups from Glaxo Smith Kline and Astra Zeneca characterized the receptor extensively because it was hoped to be responsible for the blood pressure lowering properties of cannabinoids. GPR55 is indeed activated by endogenous and exogenous cannabinoids such as plant and synthetic cannabinoids but GPR-55 knockout mice generated by a research group from Glaxo Smith Kline showed no altered blood pressure regulation after administration of the cannabidiol-derivative abnormal cannabidiol.[10]

Signal cascade[edit]

GPR55 is coupled to the G-protein G13 and activation of the receptor leads to stimulation of rhoAcdc42 and rac1.[11]

Pharmacology[edit]

GPR55 is activated by the plant cannabinoids Δ9-THC[12] and the endocannabinoids anandamide2-AG and noladin ether in the low nanomolar range. Exocannabinoids such as the synthetic cannabinoid CP-55940 are also able to activate the receptor[12] while the structurally unrelated cannabinoid mimic WIN 55,212-2 fails to activate the receptor.[10] Recent research suggests that lysophosphatidylinositol and its 2-arachidonoyl derivative, 2-arachidonoyl lysophosphatidylinositol (2-ALPI), may be the endogenous ligands for GPR55[13][14][15] and the receptor appears likely to be a possible target for treatment of inflammation and pain as with the other cannabinoid receptors.[16][17]
This profile as a distinct non-CB1/CB2 receptor which responds to a variety of both endogenous and exogenous cannabinoid ligands has led some groups to suggest GPR55 should be categorised as the CB3 receptor, and this re-classification may follow in time.[18][19][20][21] However this is complicated by the fact that another possible CB3 receptor has been discovered in the hippocampus, although its gene has not yet been cloned,[22] suggesting that there may be at least four cannabinoid receptors which will eventually be characterised. Evidence accumulated during the last few years suggests that GPR55 plays a relevant role in cancer and opens the possibility of considering this orphan receptor as a new therapeutic target and potential biomarker in oncology.[2